AP1-dependent galectin-1 expression delineates classical hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features | ||
| dc.conicet.organizacion | Harvard Medical School | |
| dc.conicet.organizacion | Dana Farber Cancer Institute | |
| dc.conicet.organizacion | Dana Farber Cancer Institute | |
| dc.conicet.organizacion | Harvard Medical School | |
| dc.conicet.organizacion | Harvard Medical School | |
| dc.conicet.organizacion | Dana Farber Cancer Institute | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental | |
| dc.conicet.organizacion | Dana Farber Cancer Institute | |
| dc.conicet.organizacion | Harvard Medical School | |
| dc.contributor.author | Rodig, Scott J. | |
| dc.contributor.author | Ouyang, Jing | |
| dc.contributor.author | Juszczynski, Przemyslaw | |
| dc.contributor.author | Currie, Treeve | |
| dc.contributor.author | Law, Kenneth | |
| dc.contributor.author | Neuberg, Donna S. | |
| dc.contributor.author | Rabinovich, Gabriel Adrián | |
| dc.contributor.author | Shipp, Margaret A. | |
| dc.contributor.author | Kutok, Jeffery L. | |
| dc.date.issued | 2008-06 | |
| dc.description.abstract | Galectin-1 is an immunomodulatory glycan-binding protein regulated by an AP1-dependent enhancer in Hodgkin Reed-Sternberg cells. We recently found that Reed Sternberg cell Gal-1 promotes the immunosuppressive T helper2/ T-regulatory cell-skewed microenvironment in classic Hodgkin lymphoma (cHL). We sought to investigate whether the the coordinate expression of activated AP1 pathway components and Gal-1 serves as a diagnostic signature of cHL. In addition, because there are common signaling and survival pahtways in cHL and additional non-Hodgkin lymphomas, we also evaluated whether the AP1/Gal1 signature is shared by other molecularly or morphologically related lymhomas. Our findings establish a functional AP1 signature that incluses Gal-1 expression in cHL and ALCL, and suggests a common mechanmism for tumor immunotolerance in these diseases. In addition, the combination of Gal1 and c-Jun serve as diagnostic biomarkers that delineate cHL and ALCL from other lymphomas with shared morphologic and/or molecular features. | es |
| dc.description.fil | Fil: Rodig, Scott J.. Harvard Medical School; Estados Unidos | |
| dc.description.fil | Fil: Ouyang, Jing. Dana Farber Cancer Institute; Estados Unidos | |
| dc.description.fil | Fil: Juszczynski, Przemyslaw. Dana Farber Cancer Institute; Estados Unidos | |
| dc.description.fil | Fil: Currie, Treeve. Harvard Medical School; Estados Unidos | |
| dc.description.fil | Fil: Law, Kenneth. Harvard Medical School; Estados Unidos | |
| dc.description.fil | Fil: Neuberg, Donna S.. Dana Farber Cancer Institute; Estados Unidos | |
| dc.description.fil | Fil: Rabinovich, Gabriel Adrián. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina | |
| dc.description.fil | Fil: Shipp, Margaret A.. Dana Farber Cancer Institute; Estados Unidos | |
| dc.description.fil | Fil: Kutok, Jeffery L.. Harvard Medical School; Estados Unidos | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Rodig, Scott J.; Ouyang, Jing; Juszczynski, Przemyslaw; Currie, Treeve; Law, Kenneth; et al.; AP1-dependent galectin-1 expression delineates classical hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features; American Association for Cancer Research; Clinical Cancer Research; 14; 11; 6-2008; 3338-3344 | es |
| dc.identifier.eissn | 1078-0432 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 1078-0432 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/25866 | |
| dc.journal.ciudad | Philadelphia | es |
| dc.journal.number | 11 | es |
| dc.journal.pagination | 3338-3344 | es |
| dc.journal.pais | Estados Unidos | es |
| dc.journal.title | Clinical Cancer Research | es |
| dc.journal.volume | 14 | es |
| dc.language.iso | eng | es |
| dc.publisher | American Association for Cancer Research | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/http://clincancerres.aacrjournals.org/cgi/pmidlookup?view=long&pmid=18519761 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1158/1078-0432.CCR-07-4709 | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.subject | Lymphomas | es |
| dc.subject | Galectin-1 | es |
| dc.subject | Ap-1 | es |
| dc.subject | Signature | es |
| dc.subject.classification | Bioquímica y Biología Molecular | es |
| dc.subject.classification | Medicina Básica | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | AP1-dependent galectin-1 expression delineates classical hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.ddc12c44-9979-4703-bace-8f6bae3b96d4_XX.pdf
- Tamaño:
- 490.3 KB
- Formato:
- Adobe Portable Document Format
- Descripción: